Abhay Chakra Sadineni

12 September 2026

The Most Expensive Mistake in Business Is Confusing Sequence with Cause

The Most Expensive Mistake in Business Is Confusing Sequence with Cause

A company raises prices and revenue grows. A hospital introduces a new technology and patients improve. A government offers a subsidy and jobs increase. The natural conclusion is that the decision created the outcome.

Maybe. But what would have happened anyway?

That missing comparison is the counterfactual, and I believe it is one of the most valuable ideas in economics. It separates a persuasive story from an honest measurement of impact.

I have spent years around technologies that promised better performance, lower cost, or greater access. The technical evidence could establish that a product worked. The commercial question was harder: what did it cause, compared with the world in which nobody adopted it?

If a factory installs predictive maintenance software and downtime falls 20 percent, the software receives credit. Yet demand may have softened, equipment may have been upgraded, or the maintenance crew may have changed. If a drug appears to reduce hospitalizations, patients receiving it may already differ from those who do not. Observation alone can make almost any investment look brilliant.

This is why causal reasoning changes decisions. It forces us to design a credible comparison, challenge selection bias, and attach value only to the incremental result. In a business, that can mean the difference between scaling a product and scaling a coincidence. In healthcare, it can mean the difference between paying for an outcome and paying for hope. In public policy, it determines whether public money solved a problem or merely arrived while the problem was changing.

The counterfactual is invisible, but it should shape every serious calculation. The real return on a technology is not the total outcome after adoption. It is the difference between that outcome and the best estimate of what would have happened without it.

Economics, at its best, disciplines ambition. It allows us to be excited by progress while asking the question enthusiasm tends to avoid: did we actually cause it?